肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌

2016-09-20 美国妇科肿瘤学会 Gynecol Oncol. 2016 Oct;143(1):3-15.

辅助化疗卵巢癌

2016年9月，美国妇科肿瘤学会(SGO)发布了新辅助化疗治疗新诊断晚期卵巢癌临床实践指南，主要目的是为新辅助化疗和间隔肿瘤细胞减灭术治疗ⅢC或IV期上皮性卵巢癌患者提供临床指导。

中文标题：

2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌

英文标题：

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.

发布机构：

美国妇科肿瘤学会

发布日期：

2016-09-20

简要介绍：

2016年9月，美国妇科肿瘤学会(SGO)发布了新辅助化疗治疗新诊断晚期卵巢癌临床实践指南，主要目的是为新辅助化疗和间隔肿瘤细胞减灭术治疗ⅢC或IV期上皮性卵巢癌患者提供临床指导。


拓展指南：与辅助化疗相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌)] GetToolGuiderByIdResponse(projectId=1, id=68ab51c001290ee4, title=2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌, enTitle=Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline., guiderFrom=Gynecol Oncol. 2016 Oct;143(1):3-15., authorId=null, author=, summary=2016年9月，美国妇科肿瘤学会(SGO)发布了新辅助化疗治疗新诊断晚期卵巢癌临床实践指南，主要目的是为新辅助化疗和间隔肿瘤细胞减灭术治疗ⅢC或IV期上皮性卵巢癌患者提供临床指导。, cover=, journalId=null, articlesId=null, associationId=1177, associationName=美国妇科肿瘤学会, associationIntro=The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women&rsquo;s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations., copyright=0, guiderPublishedTime=Tue Sep 20 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年9月，美国妇科肿瘤学会(SGO)发布了新辅助化疗治疗新诊断晚期卵巢癌临床实践指南，主要目的是为新辅助化疗和间隔肿瘤细胞减灭术治疗ⅢC或IV期上皮性卵巢癌患者提供临床指导。 <div><br> 拓展指南：<strong>与<font color=red>辅助化疗</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=68ab51c001290ee4" title="2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌" target=_blank>2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%BE%85%E5%8A%A9%E5%8C%96%E7%96%97" target=_blank>有关辅助化疗更多指南</a></ul></div>, tagList=[TagDto(tagId=1235, tagName=辅助化疗), TagDto(tagId=359, tagName=卵巢癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4883, appHits=224, showAppHits=0, pcHits=3711, showPcHits=1705, likes=147, shares=11, comments=2, approvalStatus=1, publishedTime=Wed Sep 28 23:25:59 CST 2016, publishedTimeString=2016-09-20, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Sep 28 23:25:59 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:48:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌)])
2016 SGO临床实践指南：新辅助化疗治疗新诊断晚期卵巢癌
下载请点击：
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=139042, encodeId=d81d139042db, content=o, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45ea1946638, createdName=wangbinqiao, createdTime=Sun Oct 02 14:56:04 CST 2016, time=2016-10-02, status=1, ipAttribution=)]
    2016-10-02 wangbinqiao

    o

    0